Skip to content

Neuropsychiatric Effects of Deep Brain Stimulation in Patients With Parkinson's Disease

Neuropsychiatric Effects of Deep Brain Stimulation in Patients With Parkinson's Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01306539
Enrollment
20
Registered
2011-03-02
Start date
2008-07-31
Completion date
2014-12-31
Last updated
2019-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

Keywords

deep brain stimulation, subthalamic nucleus

Brief summary

Stimulation of the subthalamic nucleus will have effects on various aspects of neuropsychiatric function.

Interventions

Stimulation is delivered to the subthalamic nucleus at experimentally prescribed settings.

Sponsors

National Alliance for Research on Schizophrenia and Depression
CollaboratorOTHER
University of California, San Diego
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Participants diagnosed with idiopathic Parkinson's disease that meet criteria for treatment of their disease with STN-DBS. Participants will be selected for this study without regard for age (provided they are older than 18), gender or ethnic background. * Participants must have undergone subthalamic nucleus DBS surgery and be receiving treatment at the Scripps Clinic in La Jolla, CA

Exclusion criteria

* Patients under 18 years old. * Patients with mini-mental status scores below 26/30. * Patients with known psychiatric disease. * Patients who are too infirm, demented or dysarthric to clearly understand the consenting process, task instructions, or to communicate verbally regarding participation or non-participation.

Design outcomes

Primary

MeasureTime frameDescription
behavioral task performance1 to 2 hoursParticipants will complete behavioral tasks at each of three visits to assess the effects of stimulation settings on task performance. At each research visit, behavior will be assessed beginning at 1 hour after the stimulation is adjusted to the experimental settings. Stimulation settings will be returned to each patient's treatment levels at the culmination of each visit.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026